ATE209920T1 - Verwendung von antimineralcorticoidverbindungen gegen das drogenentzugssyndrom - Google Patents
Verwendung von antimineralcorticoidverbindungen gegen das drogenentzugssyndromInfo
- Publication number
- ATE209920T1 ATE209920T1 AT96931876T AT96931876T ATE209920T1 AT E209920 T1 ATE209920 T1 AT E209920T1 AT 96931876 T AT96931876 T AT 96931876T AT 96931876 T AT96931876 T AT 96931876T AT E209920 T1 ATE209920 T1 AT E209920T1
- Authority
- AT
- Austria
- Prior art keywords
- antimineralcorticoid
- compounds
- drug withdrawal
- withdrawal syndrome
- warm
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9511086A FR2739029B1 (fr) | 1995-09-21 | 1995-09-21 | Nouvelle application therapeutique des composes antimineralo-corticoides |
PCT/FR1996/001459 WO1997010827A1 (fr) | 1995-09-21 | 1996-09-19 | Utilisation des composes antimineralocorticoides contre le syndrome de sevrage des narcotiques |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE209920T1 true ATE209920T1 (de) | 2001-12-15 |
Family
ID=9482793
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96931876T ATE209920T1 (de) | 1995-09-21 | 1996-09-19 | Verwendung von antimineralcorticoidverbindungen gegen das drogenentzugssyndrom |
Country Status (10)
Country | Link |
---|---|
US (3) | US6147066A (de) |
EP (1) | EP0863760B1 (de) |
JP (1) | JP2000513704A (de) |
AT (1) | ATE209920T1 (de) |
DE (1) | DE69617729T2 (de) |
DK (1) | DK0863760T3 (de) |
ES (1) | ES2166001T3 (de) |
FR (1) | FR2739029B1 (de) |
PT (1) | PT863760E (de) |
WO (1) | WO1997010827A1 (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001518509A (ja) | 1997-10-06 | 2001-10-16 | ザ ボード オブ トラスティーズ オブ レランド スタンフォード ジュニア ユニバーシティ | グルココルチコイド関連機能不全に関連した精神病の処置のための方法。 |
EP1726307A3 (de) * | 1997-10-06 | 2007-04-04 | The Board Of Trustees Of The Leland Stanford Junior University | Methode zur Behandlung von durch Glycocorticoidstörungen verursachten Psychosen |
US6787531B1 (en) | 1999-08-31 | 2004-09-07 | Schering Ag | Pharmaceutical composition for use as a contraceptive |
CA2478172A1 (en) * | 2002-03-15 | 2003-09-25 | Eli Lilly And Company | Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators |
DE102004063864A1 (de) * | 2004-12-30 | 2006-07-13 | Schering Ag | 18-Methyl-19-nor-17-pregn-4-en21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate |
US8445469B2 (en) * | 2004-12-30 | 2013-05-21 | Bayer Intellectual Property Gmbh | 18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter |
US8139039B2 (en) * | 2007-07-31 | 2012-03-20 | Kent Displays, Incorporated | Selectively erasable electronic writing tablet |
US8228301B2 (en) * | 2007-07-31 | 2012-07-24 | Kent Displays Incorporated | Multiple color writing tablet |
US7960368B2 (en) * | 2008-03-05 | 2011-06-14 | Everstra, Inc. | Bismethylene-17A carbolactones and related uses |
KR101396373B1 (ko) * | 2009-05-28 | 2014-05-19 | 켄트 디스플레이스 인코포레이티드 | 쓰기용 태블릿 정보 기록 장치 |
US9134561B2 (en) | 2011-11-01 | 2015-09-15 | Kent Displays Incorporated | Writing tablet information recording device |
US9116379B2 (en) | 2012-05-22 | 2015-08-25 | Kent Displays Incorporated | Electronic display with semitransparent back layer |
US9235075B2 (en) | 2012-05-22 | 2016-01-12 | Kent Displays Incorporated | Electronic display with patterned layer |
US10088701B2 (en) | 2013-11-01 | 2018-10-02 | Kent Displays Inc. | Electronic writing device with dot pattern recognition system |
US9851612B2 (en) | 2014-04-02 | 2017-12-26 | Kent Displays Inc. | Liquid crystal display with identifiers |
TWI646971B (zh) * | 2015-12-04 | 2019-01-11 | 鄭恩哲 | 阻斷海洛因或嗎啡毒品中毒路徑的點滴處方及其應用 |
RU2019126483A (ru) | 2017-01-23 | 2021-02-24 | Ридженерон Фармасьютикалз, Инк. | Варианты 17-бета-гидроксистероиддегидрогеназы 13 (hsd17b13) и их применение |
EP3610029A1 (de) * | 2017-04-11 | 2020-02-19 | Regeneron Pharmaceuticals, Inc. | Tests zum screening der aktivität von modulatoren von elementen der hydroxysteroid (17-beta)-dehydrogenase (hsd17b)-familie |
CN111183234A (zh) | 2017-10-11 | 2020-05-19 | 雷杰纳荣制药公司 | 在表达pnpla3 i148m变异的患者的肝病治疗中对hsd17b13的抑制 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0533517A1 (de) * | 1991-08-20 | 1993-03-24 | Chiba Flour Milling Co. Ltd. | LPS enthaltenes Anti-Entzugsmittel |
US5869474A (en) * | 1997-05-16 | 1999-02-09 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Low dosage treatment for cocaine craving and withdrawal |
-
1995
- 1995-09-21 FR FR9511086A patent/FR2739029B1/fr not_active Expired - Fee Related
-
1996
- 1996-09-19 DK DK96931876T patent/DK0863760T3/da active
- 1996-09-19 EP EP96931876A patent/EP0863760B1/de not_active Expired - Lifetime
- 1996-09-19 AT AT96931876T patent/ATE209920T1/de not_active IP Right Cessation
- 1996-09-19 US US09/043,382 patent/US6147066A/en not_active Expired - Fee Related
- 1996-09-19 DE DE69617729T patent/DE69617729T2/de not_active Expired - Fee Related
- 1996-09-19 WO PCT/FR1996/001459 patent/WO1997010827A1/fr active IP Right Grant
- 1996-09-19 PT PT96931876T patent/PT863760E/pt unknown
- 1996-09-19 ES ES96931876T patent/ES2166001T3/es not_active Expired - Lifetime
- 1996-09-19 JP JP09512443A patent/JP2000513704A/ja not_active Abandoned
-
2000
- 2000-03-27 US US09/535,711 patent/US6759399B1/en not_active Expired - Fee Related
-
2004
- 2004-06-01 US US10/858,320 patent/US20040242552A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1997010827A1 (fr) | 1997-03-27 |
DE69617729T2 (de) | 2002-08-08 |
FR2739029B1 (fr) | 1997-11-21 |
EP0863760A1 (de) | 1998-09-16 |
EP0863760B1 (de) | 2001-12-05 |
US6147066A (en) | 2000-11-14 |
PT863760E (pt) | 2002-05-31 |
DK0863760T3 (da) | 2002-04-02 |
FR2739029A1 (fr) | 1997-03-28 |
JP2000513704A (ja) | 2000-10-17 |
DE69617729D1 (de) | 2002-01-17 |
US20040242552A1 (en) | 2004-12-02 |
ES2166001T3 (es) | 2002-04-01 |
US6759399B1 (en) | 2004-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE209920T1 (de) | Verwendung von antimineralcorticoidverbindungen gegen das drogenentzugssyndrom | |
DE69738615D1 (de) | Verwendung von glp-1 oder analogen zur behandlung von myokardischem infarkt | |
DE69332624D1 (de) | WUNDHEILMITTEL UND BEHANDLUNG VON FIBROTISCHEN STORUNGEN DURCH TGFbeta-3 | |
ATE207356T1 (de) | Verwendung von tiagabin zur behandlung von schlafstörungen | |
ATE93138T1 (de) | Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie. | |
EA199700450A1 (ru) | Способы подавления миграции сосудистых гладкомышечных клеток | |
DE69829202D1 (de) | Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen | |
PT1237562E (pt) | Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas | |
DE69636907D1 (de) | Verwendung von lezithin-cholesterin-azetyltransferase für die behandlung von atherosklerose | |
EA200000693A1 (ru) | Антагонисты хемокинного рецептора и способы их применения | |
DE69733557D1 (de) | Endothelin-antagonisten zur behandlung von herzversagen | |
DE68912670D1 (de) | Behandlung von Celluloseblättern. | |
DE69924979D1 (de) | Behandlung von chronischen schmerzen | |
DE69428995T2 (de) | Verfahren zur behandlung von neoplastischen erkrankungen unter verwendung von tiazofurin und ribavirin | |
EA199800864A1 (ru) | Способ лечения при боли, вызванной мигренью | |
ATE306278T1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
ATE268170T1 (de) | Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz | |
ATE306923T1 (de) | Verwendung von (e)-metanicotinederivate als analgetika | |
DE69733321D1 (de) | Olanzapine zur behandlung von drogenmissbrauch | |
NO984198L (no) | FremgangsmÕte for behandling av aggresjon | |
EA199800820A1 (ru) | Способ лечения злоупотребления лекарственными средствами | |
RU94002713A (ru) | Способ лечения детей с синдромом удлиненного интервала qт (романо-уорда) | |
ITUD940153A0 (it) | Iniettore per iniezioni transcutanee senza ago | |
UA35855A (uk) | Спосіб лікування пилового бронхіту | |
EA200101043A1 (ru) | Способ лечения неврологических или нейропсихиатрических расстройств |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |